Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local pre-emptive hydrocortisone for pain and postoperative nausea/vomiting after laparoscopic cholecystectomy
IRCT20101211005362N26Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of hydrocortisone in postoperative pain and postoperative nausea and vomiting (PONV), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Mean postoperative pain intensity, Mean postoperative nausea and vomiting intensity and 8 more. Started Apr 2021; status: completed.
02
Drugs
hydrocortisone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20101211005362N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101211005362N26.